Bridgepoint Group (LON:BPT) Stock Price Expected to Rise, Citigroup Analyst Says

Key Points

• Citigroup raised its price target for Bridgepoint Group (LON:BPT) from GBX 360 to GBX 395, maintaining a "buy" rating, indicating a potential upside of 14.98% based on the current price.
• Other analysts, including Deutsche Bank and JPMorgan Chase, have differing price targets for Bridgepoint Group, with Deutsche Bank at GBX 345 and JPMorgan at GBX 424.
• Bridgepoint Group operates as a private equity and credit firm, focusing on various sectors such as healthcare, digital brands, and energy transition enablers.

Bridgepoint Group (LON:BPT - Free Report) had its target price upped by Citigroup from GBX 360 ($4.84) to GBX 395 ($5.31) in a research report report published on Thursday morning, MarketBeat reports. The firm currently has a buy rating on the stock.

BPT has been the subject of several other reports. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a GBX 345 ($4.64) price target on shares of Bridgepoint Group in a research note on Monday, July 21st. JPMorgan Chase & Co. restated an "overweight" rating and set a GBX 424 ($5.70) price target on shares of Bridgepoint Group in a research note on Thursday.

Bridgepoint Group Trading Up 1.3%

Bridgepoint Group stock traded up GBX 4.33 ($0.06) during trading on Thursday, hitting GBX 346.23 ($4.65). The company's stock had a trading volume of 435,103 shares, compared to its average volume of 1,782,923. The stock has a market capitalization of £2.86 billion, a price-to-earnings ratio of 62.90, a P/E/G ratio of 0.61 and a beta of 1.72. The stock's fifty day moving average is GBX 314.06 and its 200 day moving average is GBX 314.49. Bridgepoint Group has a 1-year low of GBX 229.20 ($3.08) and a 1-year high of GBX 410 ($5.51). The company has a debt-to-equity ratio of 12.89, a quick ratio of 3.60 and a current ratio of 4.98.

About Bridgepoint Group

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.